A strong case for third-party testing
2023
Fridtjof Lund-Johansen
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Show more [+] Less [-]Bibliographic information
eLife
Volume
12
ISSN
2050-084X
Publisher
eLife Sciences Publications Ltd
Other Subjects
Polyclonal antibody; Antibody specificity; Antibody validation; Recombinant antibody; Antibody
Language
English
2024-12-12
DOAJ
Data Provider
This bibliographic record has been provided by Directory of Open Access Journals
If you notice any incorrect information relating to this record, please contact us at agris@fao.org
